BOSCARO, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.964
EU - Europa 1.616
AS - Asia 1.465
SA - Sud America 12
AF - Africa 4
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 19.069
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.944
CN - Cina 714
SG - Singapore 416
FI - Finlandia 347
VN - Vietnam 288
SE - Svezia 257
DE - Germania 245
IT - Italia 217
UA - Ucraina 205
FR - Francia 161
GB - Regno Unito 106
IE - Irlanda 32
IN - India 25
NL - Olanda 17
CA - Canada 11
BZ - Belize 8
HK - Hong Kong 7
PE - Perù 7
RU - Federazione Russa 7
RO - Romania 5
TR - Turchia 5
BR - Brasile 4
ES - Italia 4
EU - Europa 4
JP - Giappone 3
NZ - Nuova Zelanda 3
PH - Filippine 3
PL - Polonia 3
BE - Belgio 2
BG - Bulgaria 2
SD - Sudan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
HR - Croazia 1
LU - Lussemburgo 1
MA - Marocco 1
NG - Nigeria 1
SI - Slovenia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 19.069
Salva come PNG Salva come JPEG
Città #
Fairfield 2.595
Woodbridge 1.978
Ann Arbor 1.487
Houston 1.416
Chandler 1.116
Ashburn 1.047
Wilmington 962
Jacksonville 920
Cambridge 912
Seattle 854
Princeton 429
Singapore 307
Dong Ket 288
San Diego 241
Roxbury 182
Beijing 166
Nanjing 140
Des Moines 135
Medford 130
Helsinki 119
Boardman 116
Padova 90
Guangzhou 62
Santa Clara 62
Shenyang 50
Hebei 34
Dublin 32
Norwalk 32
Nanchang 31
Redwood City 30
Jiaxing 27
Changsha 25
Tianjin 24
Falls Church 16
New York 16
London 15
Ogden 15
Washington 15
Jinan 12
Kharkiv 12
Dallas 11
Rome 11
Frankfurt am Main 10
Orange 10
San Jose 10
Borås 9
Columbus 9
Detroit 9
Kunming 9
Milan 9
Belize City 8
Dearborn 7
Los Angeles 7
San Francisco 7
Tappahannock 7
Zhengzhou 7
Hangzhou 6
Kilburn 6
Lima 6
Haikou 5
Hefei 5
Indiana 5
Pune 5
Rockville 5
Southwark 5
Hong Kong 4
Nürnberg 4
Vicenza 4
Albuquerque 3
Chicago 3
Chiswick 3
Foglianise 3
Hounslow 3
Hyderabad 3
Iasi 3
Kastamonu 3
Munich 3
Paris 3
Phoenix 3
Saint Louis 3
Samarate 3
Turin 3
Wandsworth 3
Anguillara Veneta 2
Ankara 2
Bologna 2
Bucharest 2
Buffalo 2
Chongqing 2
Florence 2
Groningen 2
Hanover 2
Henderson 2
Karasawa 2
Lappeenranta 2
Madrid 2
Magdeburg 2
Menlo Park 2
Mestre 2
Mumbai 2
Totale 16.419
Salva come PNG Salva come JPEG
Nome #
A constitutive active MAPK/ERK pathway due to BRAFV600E positively regulates AHR pathway in PTC 159
THE NATURAL HISTORY OF AUTOIMMUNE ADDISON'S DISEASE FROM THE DETECTION OF AUTOANTIBODIES TO DEVELOPMENT OF THE DISEASE: A LONG FOLLOW-UP STUDY ON 143 PATIENTS 150
Age-related changes in glucocorticoid fast feedback inhibition of adrenocorticotropin in man 149
Age and the metabolic syndrome affect salivary cortisol rhythm: Data from a community sample 138
Adrenocortical carcinoma: Experience in 45 patients 132
Screening tests for cushing's syndrome: Urinary free cortisol role measured by LC-MS/MS 129
Effect of ketanserin in primary aldosteronism. 128
First-line screening tests for Cushing's syndrome in patients with adrenal incidentaloma: the role of urinary free cortisol measured by LC-MS/MS 128
SELECTIVE VENOUS SAMPLING IN THE DIFFERENTIAL-DIAGNOSIS OF ACTH-DEPENDENT CUSHINGS-SYNDROME 127
A venous thromboembolism risk assessment model for patients with Cushing’s syndrome 127
Effect of metoclopramide on plasma aldosterone in normal subjects, primary aldosteronism and hypopituitarism. 126
Effect of surgical treatment on hypertension in Cushing's syndrome 125
Effects of Taxol on the human NCI-H295 adrenocortical carcinoma cell line. 123
An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: A single-centre experience 123
Temozolomide and pasireotide treatment for aggressive pituitary adenoma: expertise at a tertiary care center. 122
Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors 121
25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese 121
Improved salivary cortisol rhythm with dual-release hydrocortisone 119
New insight into the Hypercoagulability of Cushing's Syndrome 117
Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial. 117
Aldosterone, calcium, and hypertension. 115
Metyrapone treatment in Cushing’s syndrome: a real-life study 115
Adrenocortical scintigraphic characterization of incidentally discovered adrenal massess 114
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. 114
Systematic review of surgical treatment of subclinical Cushing's syndrome 112
In situ analysis of human menin in normal and neoplastic pancreatic tissues: Evidence for differential expression in exocrine and endocrine cells 112
Synergistic antitumour activity of RAF265 and ZSTK474 on human TT medullary thyroid cancer cells 112
Bone complications in patients with Cushing's syndrome: looking for clinical, biochemical, and genetic determinants. 111
The medical treatment with pasireotide in Cushing's disease: an Italian multicentre experience based on "real-world evidence" 111
Gene therapy of thyroid cancer via retrovirally-driven combined expression of human interleukin-2 and Herpes Simplex Virus thymidine kinase 110
24-HOUR BLOOD-PRESSURE PROFILE IN ADDISONS-DISEASE 109
Spironolactone and intermenstrual bleeding in polycystic ovary syndrome with normal BMI 109
Transcriptionally targeted retroviral vector for combined suicide and immunomodulating gene therapy of thyroid cancer 108
Effect of adrenocorticotropic hormone stimulation during adrenal vein sampling in primary aldosteronism 108
LIFE EVENTS IN THE PATHOGENESIS OF GRAVES-DISEASE - A CONTROLLED-STUDY 107
Association of primary aldosteronism with chronic thyroiditis 107
PATTERNS OF ACTH RESPONSE TO OCRH IN CUSHINGS-DISEASE - CORRELATION WITH HISTOLOGICAL/IMMUNOCYTOCHEMICAL FINDINGS 106
Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. 106
Effect of digoxin on the in vitro secretion of renin and angiotensin II/III immunoreactivity by the human adrenal gland 105
Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency 105
Plasma renin activity and urinary aldosterone in acromegaly. 104
Medical Treatment for Acromegaly does not Increase the Risk of Central Adrenal Insufficiency: A Long-Term Follow-Up Study 104
Comment - Is there a role for low doses of mitotane (o,p '-DDD) as adjuvant therapy in adrenocortical carcinoma? 103
Prevalence and natural history of adrenal incidentalomas. 103
Evaluation of circulating thyroid-specific transcripts as markers of thyroid cancer relapse 102
Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study 102
EFFECTS OF INHALED BECLOMETHASONE ON AIRWAY RESPONSIVENESS IN OCCUPATIONAL ASTHMA - PLACEBO-CONTROLLED STUDY OF SUBJECTS SENSITIZED TO TOLUENE DIISOCYANATE 101
Risk factors and long-term outcome in pituitary-dependent Cushing's disease 101
The diagnostic performance of urinary free cortisol is better than the cortisol:cortisone ratio in detecting de novo Cushing's syndrome: the use of a LC-MS/MS method in routine clinical practice 101
Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome 101
Development of overt Cushing's syndrome in patients with adrenal incidentaloma 101
In vitro evidence for local generation of renin and angiotensin II/III immunoreactivity by the human adrenal gland 100
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype 100
Mitogen-Activated Protein Kinase Pathway: Genetic Analysis of 95 Adrenocortical Tumors. 100
Persistent psychological distress in patients treated for endocrine disease 99
A clinical index for rating severity in Cushing's syndrome 97
Adrenal incidentalomas. A proposal for an evaluation score. 97
Effect of serotonin on plasma aldosterone in man. 96
Effect of angiotensin II and converting enzyme inhibitor (captopril) on blood pressure, plasma renin activity and aldosterone in primary aldosteronism. 96
Diagnosis and management of adrenal incidentalomas 96
Inhibitory effect of somatostatin on the aldosterone response to angiotensin II: in vitro studies. 95
Investigation of N-cadherin/β-catenin expression in adrenocortical tumors 95
DEFECTS OF STEROIDOGENESIS. 94
Opioid modulation of normal and pathological human chromaffin tissue. 94
The prevalence of HTLV-III and HTLV-I antibodies in serum of hemophiliacs. 94
ANXIETY SENSITIVITY IN ESSENTIAL-HYPERTENSION 94
Secondary Arterial Hypertension: From Routine Clinical Practice to Evidence in Patients with Adrenal Tumor 94
Overnight dexamethasone suppression of cortisol is associated with radiocholesterol uptake patterns in adrenal incidentalomas 93
Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome 93
Paclitaxel is an effective antiproliferative agent on the human NCI-H295 adrenocortical carcinoma cell line. 93
Evaluation of angiotensin II type-1 receptor antibodies in primary aldosteronism and further considerations about their possible pathogenetic role 93
Psychosocial impairment in patients treated for pituitary disease: a controlled study 92
Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome 92
Early adrenal hypofunction in patients with organ-specific autoantibodies and no clinical adrenal insufficiency. 92
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes 92
The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line 92
Endocrine aspects of cancer gene therapy 92
New perspectives for gene therapy in endocrinology 91
Effect of naloxone on the adrenal cortex in primary aldosteronism. 91
New insights to the potential mechanisms driving coronary flow reserve impairment in Cushing's syndrome: A pilot noninvasive study by transthoracic Doppler echocardiography 91
DISSEMINATED NOCARDIOSIS IN A PATIENT WITH CUSHINGS-SYNDROME 90
Gene therapy for thyroid cancer 90
LOW-DOSE KETOCONAZOLE TREATMENT IN HIRSUTE WOMEN 90
LA PHLEBOGRAPHIE SURRENALIENNE DANS L'HYPERALDOSTERONISME PRIMAIRE. 89
A pilot study of combined suicide/cytokine gene therapy in two patients with end-stage anaplastic thyroid carcinoma 89
Role of bilateral adrenalectomy in Cushing's disease 89
Effects of naloxone on adrenal cortex regulation in patients with primary aldosteronism. 89
Managing Cushing's disease: the state of the art. 88
Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors. 88
Pasireotide treatment reduces cardiometabolic risk in Cushing’s disease patients: an Italian, multicenter study 88
Evaluation and implications of salt intake and excretion 88
Steroids and Hypertension 88
POTENTIAL THERAPEUTIC EFFECTS OF RITANSERIN IN CUSHINGS-DISEASE 87
Risk factors and long-term follow-up of adrenal incidentalomas 87
Recovery of bone mineral density after surgical cure, but not by ketoconazole treatment, in Cushing's syndrome 87
Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications 87
Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH dependent Cushing's syndrome 87
Modulation of retrovirally driven therapeutic genes by mutant TP53 in anaplastic thyroid carcinoma 86
Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. 85
Cardiovascular autonomic dysfunction in patients with idiopathic diabetes insipidus 85
Totale 10.395
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.107
article - articoli 61.068
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.016
Totale 125.191
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.381 0 0 0 518 432 344 391 463 439 359 227 208
2020/20212.643 125 212 84 230 102 250 97 247 391 198 276 431
2021/20223.196 67 395 388 253 135 193 171 355 132 70 346 691
2022/20232.335 560 227 32 280 382 318 13 142 256 9 84 32
2023/2024865 44 123 112 56 75 76 55 46 21 17 117 123
2024/2025611 15 260 221 115 0 0 0 0 0 0 0 0
Totale 19.248